Capsovision Inc (CV)

$7.02 -0.17 (-2.36%)
Market Cap 359.24M
Revenue (ttm) 13.55M
Net Income (ttm) -25.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -186.86%
Debt to Equity Ratio 0.00
Volume 98,600
Avg Vol 126,272
Day's Range N/A - N/A
Shares Out 49.96M
Stochastic %K 43%
Beta N/A
Analysts Sell
Price Target $10.00

Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoClou...

Industry: Medical Devices
Sector: Healthcare
Phone: 408 624 1488
Fax: 408 370 4795
Address:
18805 Cox Avenue, Suite 250, Saratoga, United States
Doozio
Doozio Jun. 4 at 3:25 PM
$CV all da 🐑 been SPOT ONTA 🐒🍌🧠⏰♾️
0 · Reply
SuperGreenToday
SuperGreenToday May. 18 at 4:27 PM
$CV
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:34 PM
$CV (-9.6% pre) CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down https://ooc.bz/l/102475
0 · Reply
MarketBeat
MarketBeat May. 14 at 11:11 PM
https://marketbeat.com/a/8655097/ $CV CapsoVision Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 14 at 9:15 PM
https://www.marketbeat.com/earnings/reports/2026-5-14-capsovision-inc-stock/ $CV CapsoVision Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 8:14 PM
$CV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 up 94.00% YoY • Reported revenue of $2.79M up 0.32% YoY • CapsoVision anticipates mid-year FDA clearance for its AI-assisted reading feature for CapsoCam Plus, with commercial launch expected shortly thereafter, subject to FDA review timelines.
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 12:58 PM
$CV Current Stock Price: $6.80
0 · Reply
anachartanalyst
anachartanalyst Mar. 27 at 8:02 PM
$CV https://anachart.com/wp-content/uploads/ana_temp/1774641710_soc-img.jpg
0 · Reply
BioGem
BioGem Mar. 27 at 3:59 AM
$CV I will re-short this name after their disastrous Q4 report, while its market cap is strangely too inflated. Many negatives: -Again, for numerous times now, they are delaying their research and application for approval for the colonic capsule (won't be launched till late 2027). -Revenue has slow growth in the low teens. -GM is too low and dropping. -Op Losses are deeper every quarter, with faster cash burn. -Cash is near zero by summer 2026. A repeat dilution is a certainty. -No catalyst for the next year. -Short interest is going up quickly = expect poor performance.
0 · Reply
BioGem
BioGem Mar. 27 at 3:55 AM
$CV @Stocktwits please correct the name of this company, it should be Capsovision, Inc
0 · Reply
Latest News on CV
CapsoVision Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

CapsoVision Earnings Call Transcript: Q1 2026

CapsoVision Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

CapsoVision Earnings release: Q1 2026

CapsoVision Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

CapsoVision Quarterly report: Q1 2026

CapsoVision Reports First Quarter 2026 Financial Results

May 14, 2026, 4:05 PM EDT - 25 days ago

CapsoVision Reports First Quarter 2026 Financial Results

CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026

Apr 30, 2026, 4:05 PM EDT - 5 weeks ago

CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026

CapsoVision Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

CapsoVision Proxy statement: Proxy filing

CapsoVision files to sell 2.87M shares of common stock for holders

2026-04-17T20:40:16.000Z - 7 weeks ago

CapsoVision files to sell 2.87M shares of common stock for holders

CapsoVision Registration statement: Registration filing

Apr 17, 2026, 8:00 AM EDT - 7 weeks ago

CapsoVision Registration statement: Registration filing

CapsoVision price target lowered to $10 from $14 at Benchmark

2026-03-27T12:37:49.000Z - 2 months ago

CapsoVision price target lowered to $10 from $14 at Benchmark

CapsoVision Earnings Call Transcript: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 2 months ago

CapsoVision Earnings Call Transcript: Q4 2025

CapsoVision Annual report: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 2 months ago

CapsoVision Annual report: Q4 2025

CapsoVision Earnings release: Q4 2025

Mar 26, 2026, 4:30 PM EDT - 2 months ago

CapsoVision Earnings release: Q4 2025

CapsoVision Slides: Corporate presentation

Mar 26, 2026, 4:00 PM EDT - 2 months ago

CapsoVision Slides: Corporate presentation

CapsoVision price target raised to $11 from $7 at Roth Capital

2026-03-24T11:46:49.000Z - 2 months ago

CapsoVision price target raised to $11 from $7 at Roth Capital

CapsoVision Transcript: The 38th Annual Roth Conference

Mar 23, 2026, 1:30 PM EDT - 2 months ago

CapsoVision Transcript: The 38th Annual Roth Conference

CapsoVision jumps over 20% after announcing preliminary Q4 revenue

2026-03-23T15:25:39.000Z - 2 months ago

CapsoVision jumps over 20% after announcing preliminary Q4 revenue

CapsoVision price target raised to $11 from $7 at Roth Capital

2026-03-23T15:15:08.000Z - 2 months ago

CapsoVision price target raised to $11 from $7 at Roth Capital

CapsoVision announces $14M private placement financing

2026-03-20T12:15:14.000Z - 2 months ago

CapsoVision announces $14M private placement financing

CapsoVision Announces $14 Million Private Placement Financing

Mar 20, 2026, 8:00 AM EDT - 2 months ago

CapsoVision Announces $14 Million Private Placement Financing

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

Mar 12, 2026, 4:05 PM EDT - 3 months ago

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

CapsoVision price target raised to $14 from $5 at Benchmark

2025-12-31T12:20:21.000Z - 5 months ago

CapsoVision price target raised to $14 from $5 at Benchmark

CapsoVision submits 510(k) application to FDA for CapsoCam Plus

2025-12-29T21:10:26.000Z - 5 months ago

CapsoVision submits 510(k) application to FDA for CapsoCam Plus

CapsoVision Inc trading halted, volatility trading pause

2025-12-19T21:00:34.000Z - 6 months ago

CapsoVision Inc trading halted, volatility trading pause

CapsoVision Inc trading resumes

2025-12-19T21:00:16.000Z - 6 months ago

CapsoVision Inc trading resumes

CapsoVision Inc trading resumes

2025-12-09T16:40:40.000Z - 6 months ago

CapsoVision Inc trading resumes

CapsoVision Inc trading halted, volatility trading pause

2025-12-09T16:30:30.000Z - 6 months ago

CapsoVision Inc trading halted, volatility trading pause

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

Nov 20, 2025, 4:05 PM EST - 7 months ago

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

CapsoVision Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

CapsoVision Earnings Call Transcript: Q3 2025

CapsoVision Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

CapsoVision Quarterly report: Q3 2025

CapsoVision Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

CapsoVision Earnings release: Q3 2025

CapsoVision reports Q3 EPS (17c) vs ($2.79) last year

2025-11-13T21:26:05.000Z - 7 months ago

CapsoVision reports Q3 EPS (17c) vs ($2.79) last year

CapsoVision submits CapsoCam breakthrough device designation application to FDA

2025-11-10T22:00:43.000Z - 7 months ago

CapsoVision submits CapsoCam breakthrough device designation application to FDA

CapsoVision resumed with a Buy at Roth Capital

2025-11-04T09:20:24.000Z - 7 months ago

CapsoVision resumed with a Buy at Roth Capital

CapsoVision appoints David Garcia as SVP, finance

2025-11-03T13:11:07.000Z - 7 months ago

CapsoVision appoints David Garcia as SVP, finance

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

Oct 30, 2025, 4:05 PM EDT - 7 months ago

CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

CapsoVision Slides: Corporate Presentation

Sep 10, 2025, 7:00 AM EDT - 9 months ago

CapsoVision Slides: Corporate Presentation

CapsoVision CFO Lundquist steps down

2025-09-03T23:25:11.000Z - 9 months ago

CapsoVision CFO Lundquist steps down

CapsoVision Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

CapsoVision Earnings Call Transcript: Q2 2025

CapsoVision Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

CapsoVision Quarterly report: Q2 2025

CapsoVision Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

CapsoVision Earnings release: Q2 2025

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Jul 31, 2025, 4:05 PM EDT - 11 months ago

CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025

CapsoVision Announces Closing of Initial Public Offering

Jul 3, 2025, 11:50 AM EDT - 1 year ago

CapsoVision Announces Closing of Initial Public Offering

CapsoVision Announces Pricing of Initial Public Offering

Jul 1, 2025, 9:08 PM EDT - 1 year ago

CapsoVision Announces Pricing of Initial Public Offering

CapsoVision Registration statement: Registration Filing

Jun 27, 2025, 8:00 AM EDT - 1 year ago

CapsoVision Registration statement: Registration Filing

CapsoVision Registration statement: Registration Filing

Jun 13, 2025, 8:00 AM EDT - 1 year ago

CapsoVision Registration statement: Registration Filing

CapsoVision Registration statement: Registration Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

CapsoVision Registration statement: Registration Filing

Medical device maker CapsoVision files for a $30 million IPO

May 9, 2025, 5:52 PM EDT - 1 year ago

Medical device maker CapsoVision files for a $30 million IPO

CapsoVision IPO Registration Document (S-1)

May 9, 2025, 4:11 PM EDT - 1 year ago

CapsoVision IPO Registration Document (S-1)

Doozio
Doozio Jun. 4 at 3:25 PM
$CV all da 🐑 been SPOT ONTA 🐒🍌🧠⏰♾️
0 · Reply
SuperGreenToday
SuperGreenToday May. 18 at 4:27 PM
$CV
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:34 PM
$CV (-9.6% pre) CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down https://ooc.bz/l/102475
0 · Reply
MarketBeat
MarketBeat May. 14 at 11:11 PM
https://marketbeat.com/a/8655097/ $CV CapsoVision Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 14 at 9:15 PM
https://www.marketbeat.com/earnings/reports/2026-5-14-capsovision-inc-stock/ $CV CapsoVision Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 8:14 PM
$CV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 up 94.00% YoY • Reported revenue of $2.79M up 0.32% YoY • CapsoVision anticipates mid-year FDA clearance for its AI-assisted reading feature for CapsoCam Plus, with commercial launch expected shortly thereafter, subject to FDA review timelines.
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 29 at 12:58 PM
$CV Current Stock Price: $6.80
0 · Reply
anachartanalyst
anachartanalyst Mar. 27 at 8:02 PM
$CV https://anachart.com/wp-content/uploads/ana_temp/1774641710_soc-img.jpg
0 · Reply
BioGem
BioGem Mar. 27 at 3:59 AM
$CV I will re-short this name after their disastrous Q4 report, while its market cap is strangely too inflated. Many negatives: -Again, for numerous times now, they are delaying their research and application for approval for the colonic capsule (won't be launched till late 2027). -Revenue has slow growth in the low teens. -GM is too low and dropping. -Op Losses are deeper every quarter, with faster cash burn. -Cash is near zero by summer 2026. A repeat dilution is a certainty. -No catalyst for the next year. -Short interest is going up quickly = expect poor performance.
0 · Reply
BioGem
BioGem Mar. 27 at 3:55 AM
$CV @Stocktwits please correct the name of this company, it should be Capsovision, Inc
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 26 at 8:14 PM
$CV Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.02 up 100.90% YoY • Reported revenue of $3.92M up 13.50% YoY
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 25 at 9:25 PM
$CV
0 · Reply
SadyK189
SadyK189 Mar. 25 at 8:04 PM
Here is my Amazing daily "Stocktwits" report 2/2: $FEED $ROMA $TNGX $CV FEED Price 2.23. My post last night "Getting up on 4hours chart. Key support at 1.6 - 1.8. Next key level to test 2.65 - 2.85." It hit our desired zone and went till 2.88 today CV Price 8.15. My post was "Looking good on daily chart. Key support at 6.7 - 7.10. Next key level to test 8.8 - 9.2." It hit our desired zone and went till 9.17 today ROMA Price 5.37. My post last night "Still looking good on daily chart. Next key level to test is 8.9 - 9.35." It made a nice move to 11.60 today TNGX Initially alerted at 16.85. Then posted "Next key level to test is 21.10 - 21.70". It hit our desired zone and went till 21.80 today
1 · Reply
SadyK189
SadyK189 Mar. 25 at 6:22 PM
Mid-Day Update 🚀 🎯 Levels respected perfectly: $UGRO → called at 3.99 → went till 16.69 (+318%) 🚀 $FEED → called at 2.23 → went till 2.88 (+29%) ✅ $SATL → called at 4.89 → went till 6.83 (+40%) 🚀 $MKDW → called at 3.18 → went till 4.83 (+52%) 📈 $CV → called at 8.15 → went till 9.17 (+13%) 💰 All levels shared earlier (in detailed posts) and reacting cleanly.
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Mar. 25 at 2:37 PM
$CV Stalled atm. Once the Bull runs resumes, lots of money to be made when you hop on the institution train. $NAUT $APA $GLNG Congrats bulls. Tuts loaded
0 · Reply
SadyK189
SadyK189 Mar. 25 at 2:08 PM
$CV My post was "Looking good on daily chart. Key support at 6.7 - 7.10. Next key level to test 8.8 - 9.2. Currently at 8.15" It went till 9.17 a while ago
0 · Reply
SadyK189
SadyK189 Mar. 24 at 8:22 PM
Here is my Amazing daily "Stocktwits" report 2/2: $LICN $ASNS $SUNE $ORIS $CV LICN Price 4.12. My post last night "Good close of daily candle. Key support at 3.1 - 3.35. Next key level to test 4.7 - 5." It hit our desired zone and went till 5.94 today ASNS Price 0.4. My post last night "Getting up on 4hours chart. 0.31 - 0.33 is acting as key support zone. Next key level to test 0.48 - 0.52." It hit our desired zone and went till 0.5413 SUNE Price 2.35. My post was "Good close of daily candle. 1.6 - 1.78 is acting as key support zone. Next key level to test 2.95 - 3.25." It went till 2.91 today ORIS Price 0.57. My post last night "Getting up on 4hours chart. Key support at 0.5150 - 0.54. Next key level to test 0.77 - 0.81." It hit our desired zone and went till 0.7949 today CV Price 8.15. My post last night "Looking good on daily chart. Key support at 6.7 - 7.10. Next key level to test 8.8 - 9.2." It went till 8.79 today
0 · Reply
SadyK189
SadyK189 Mar. 24 at 3:44 AM
Top Stocks to watch tomorrow 2 / 2: $SER $NAMI $BNGO $BIAF $CV SER: Alerted on weekend at 2.54. Still looking good on daily chart. Key support at 2.25 - 2.5. Next key level to test 3.55 - 3.70. Currently at 3.12 NAMI: Looking good on 4hours chart. Key support at 0.62 - 0.66. Next key level to test is 0.94 - 0.98. Currently at 0.8 BNGO: Good close of daily candle. 1.05 - 1.18 is acting as key support zone. Next key level to test 1.85 - 2.05. Currently at 1.48 BIAF: Given next key levels at 3.01. Currently at 4.52. Still trending nicely on daily chart. Key support at 3.3 - 3.65. Next key level to test is 5.30 - 5.7. CV: Looking good on daily chart. Key support at 6.7 - 7.10. Next key level to test 8.8 - 9.2. Currently at 8.15
1 · Reply
StockScanners
StockScanners Mar. 24 at 2:55 AM
$CV reached 8.95! lets go team, we on a roll
0 · Reply
StockScanners
StockScanners Mar. 24 at 2:10 AM
$CV keep watch if this holds above 7.75
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Mar. 23 at 7:06 PM
$CV multi day runner
0 · Reply